Cargando…

Acute interstitial nephritis and drug rash with secondary to Linezolid

Linezolid, a member of oxazolidinone antibiotic class, is a relatively well-tolerated drug with few side effects. It is active against gram-positive cocci, including multidrug resistant staphylococci and enterococci. We report a case of a 54-year-old diabetic male with alcoholic cirrhosis admitted i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, S., Nandwani, A., Rastogi, A., Gupta, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544059/
https://www.ncbi.nlm.nih.gov/pubmed/23326048
http://dx.doi.org/10.4103/0971-4065.103918
_version_ 1782255736293687296
author Nayak, S.
Nandwani, A.
Rastogi, A.
Gupta, V.
author_facet Nayak, S.
Nandwani, A.
Rastogi, A.
Gupta, V.
author_sort Nayak, S.
collection PubMed
description Linezolid, a member of oxazolidinone antibiotic class, is a relatively well-tolerated drug with few side effects. It is active against gram-positive cocci, including multidrug resistant staphylococci and enterococci. We report a case of a 54-year-old diabetic male with alcoholic cirrhosis admitted in intensive care unit with altered sensorium. He was diagnosed as a case of hepatic failure secondary to hepatitis E infection and enterococcal urosepsis. He was started on linezolid based on the urine culture sensitivity report. On day three of linezolid treatment, he developed severe pruritus, macular rash, eosinophilia, and renal dysfunction. Renal biopsy showed acute tubulointerstitial nephritis. Renal functions improved on discontinuation of linezolid and short course of steroid therapy.
format Online
Article
Text
id pubmed-3544059
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35440592013-01-16 Acute interstitial nephritis and drug rash with secondary to Linezolid Nayak, S. Nandwani, A. Rastogi, A. Gupta, V. Indian J Nephrol Case Report Linezolid, a member of oxazolidinone antibiotic class, is a relatively well-tolerated drug with few side effects. It is active against gram-positive cocci, including multidrug resistant staphylococci and enterococci. We report a case of a 54-year-old diabetic male with alcoholic cirrhosis admitted in intensive care unit with altered sensorium. He was diagnosed as a case of hepatic failure secondary to hepatitis E infection and enterococcal urosepsis. He was started on linezolid based on the urine culture sensitivity report. On day three of linezolid treatment, he developed severe pruritus, macular rash, eosinophilia, and renal dysfunction. Renal biopsy showed acute tubulointerstitial nephritis. Renal functions improved on discontinuation of linezolid and short course of steroid therapy. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3544059/ /pubmed/23326048 http://dx.doi.org/10.4103/0971-4065.103918 Text en Copyright: © Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Nayak, S.
Nandwani, A.
Rastogi, A.
Gupta, V.
Acute interstitial nephritis and drug rash with secondary to Linezolid
title Acute interstitial nephritis and drug rash with secondary to Linezolid
title_full Acute interstitial nephritis and drug rash with secondary to Linezolid
title_fullStr Acute interstitial nephritis and drug rash with secondary to Linezolid
title_full_unstemmed Acute interstitial nephritis and drug rash with secondary to Linezolid
title_short Acute interstitial nephritis and drug rash with secondary to Linezolid
title_sort acute interstitial nephritis and drug rash with secondary to linezolid
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544059/
https://www.ncbi.nlm.nih.gov/pubmed/23326048
http://dx.doi.org/10.4103/0971-4065.103918
work_keys_str_mv AT nayaks acuteinterstitialnephritisanddrugrashwithsecondarytolinezolid
AT nandwania acuteinterstitialnephritisanddrugrashwithsecondarytolinezolid
AT rastogia acuteinterstitialnephritisanddrugrashwithsecondarytolinezolid
AT guptav acuteinterstitialnephritisanddrugrashwithsecondarytolinezolid